Reach Us 15038746074

Sirtuin 1 and Adenosine in Brain Disorder Therapy

Ian James Martins*

Centre of Excellence in Alzheimer’s Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Australia

*Corresponding Author:
Dr Ian Martins
Centre of Excellence in Alzheimer’s Disease Research and Care
School of Medical and Health Sciences
Edith Cowan University, 270 Joondalup Drive
Joondalup, 6027, Australia
Tel: +61863042574
E-mail: [email protected]

Received Date: March 20, 2017; Accepted Date: March 25, 2017; Published Date: March 28, 2017

Citation: Martins IJ. Sirtuin 1 and Adenosine in Brain Disorder Therapy. J Clin Epigenet. 2017, 3:1. doi: 10.21767/2472-1158.100045

Visit for more related articles at Journal of Clinical Epigenetics

The neuromodulatory role of adenosine and regulation of brain disorders by Adenosine Receptors (AR) has become critical to brain disorder therapy in different neurodegenerative conditions such as epilepsy, Parkinson's or Alzheimer's disease. Adenosine as a neuromodulator [1] Activates A1 Receptors (A1R) and facilitatory A2A Receptors (A2AR). Disruption of adenosine homeostasis results in seizures with adenosine induction of epigenetic changes by hypomethylation of DNA and inhibition of DNA methylation (epileptogenesis) [2,3]. Brain inflammation and induction of various neurodegenerative diseases now involve adenosine with its therapy [2] relevant to epilepsy and prevention of bacterial Lipopolysaccharide (LPS) induced neuroinflammation through the AR receptors [4,5]. Connections between the anti-aging gene Sirtuin 1 (Sirt 1) [6,7] and AR receptors [1] are relevant to epigenetics (DNA methylation), glucose and lipid metabolism in chronic diseases such as NAFLD, cardiovascular disease and neurodegeneration [8,9]. Diet, LPS and the Sirt 1 have become important to epilepsy with mitochondrial function essential to the prevention of oxidative stress induced by seizures [8,10]. LPS is a critical repressor of Sirt 1 and a competitive inhibitor of many cell functions such as glucose, cholesterol and mitochondrial biogenesis [8,11]. Adenosine treatment with relevance to epileptogenesis [2,3] requires intact cell Sirt 1 activity to maintain epigenetic changes, synaptic plasticity [12- 14] and neuron survival. Sirt 1 and its regulation of NO [15] in the brain is primary to epilepsy/epigenetics [16,17] with effects of adenosine secondary with relevance to NO cell homeostasis [18,19], epilepsy [2,3] and brain disorder therapy.


Select your language of interest to view the total content in your interested language

Viewing options

Recommended Conferences
Post your comment

Share This Article

Flyer image

Post your comment

captcha   Reload  Can't read the image? click here to refresh